It could be hypothesized that compensatory upregulation of tubular SGLT-1 in advanced stages of CKD may result in increased sodium–glucose co-transport, causing afferent arteriolar re-dilatation and an increase in renal perfusion and eGFR. Here, SLC5A1 is linked to chronic kidney disease.